Значения термина cutaneous t на английском

Early stage disease and hypopigmented presentation are characteristic of pediatric cutaneous T-cell lymphoma.

We report the first observation of Sweet's syndrome associated with cutaneous T cell lymphoma.

However, the panel of antibodies currently available stains only a minority of cutaneous T-cell lymphomas.

The Notch pathway is important for survival of cutaneous T-cell lymphoma (CTCL) cells.

Further study of bexarotene photo(chemo)therapy in cutaneous T-cell lymphoma and psoriasis is warranted.

BBI-3000 is an oral rexinoid for cutaneous T-cell lymphoma.

In addition, the reader will appreciate the challenges in diagnosing and treating pediatric cutaneous T-cell lymphoma.

Interferon plus PUVA appear to be highly effective regimens for the treatment of patients with cutaneous T-cell lymphomas.

The most likely scenario is that PRL enhances interferon-induced chemokine production in keratinocytes, thereby facilitating cutaneous T-cell infiltration.

We conclude that cytologic transformation in cutaneous T cell lymphoma represents a distinct clinicopathologic entity, characterized by an aggressive clinical course.

Bexarotene is approved for the treatment of cutaneous T cell lymphomas in patients refractory to at least one prior systemic therapy.

A collaborative work has allowed to classify and evaluate in a more standardized way cutaneous T lymphomas and should help future trials.

We investigated the interleukin-1 level in epidermis of patients with cutaneous T-cell lymphoma using both immunohistochemistry, enzyme-linked immunosorbent assays, and the thymocyte co-stimulation assay.

In patients with cutaneous T-cell lymphoma (CTCL) bacterial infections constitute a major clinical problem caused by compromised skin barrier and a progressive immunodeficiency.

T cells play a pathogenic role in many inflammatory and certain malignant skin diseases, including psoriasis, atopic and allergic contact dermatitis, and cutaneous T-cell lymphoma.

Cyclacel is now focusing its clinical development priorities on sapacitabine in acute myeloid leukemia in the elderly, in myelodysplastic syndromes and in cutaneous T-cell lymphoma.